Corpus Intelligence IC Memo — UNITY SPECIALITY HOSPITAL 2026-04-26 09:56 UTC
IC Memo — UNITY SPECIALITY HOSPITAL
Investment Committee Memorandum | NY | 33 beds | Grade D | EBITDA uplift $341K
🛡️ Public data only — no PHI permitted on this instance.
Investment Committee Memorandum

UNITY SPECIALITY HOSPITAL

CCN 330411 | nan, NY | 33 beds | April 26, 2026
EBITDA BridgeData Room
D
Investability

1. Target Overview & Investment Thesis

UNITY SPECIALITY HOSPITAL is a 33-bed community hospital in nan, NY with $4.5M in net patient revenue and a -100.0% operating margin. The hospital serves a payer mix of 0.0% Medicare, 0.0% Medicaid, and 100.0% commercial.

Thesis: Turnaround. Our ML models identify $341K in annual EBITDA improvement potential from RCM optimization across 5 levers, lifting margin from -100.0% to -154.9% (+764bps).

Net Revenue HCRIS$4.5M
Current EBITDA COMPUTED$-7.3M
Operating Margin COMPUTED-100.0%
Occupancy HCRISnan%
Revenue / Bed COMPUTED$135K
Net-to-Gross HCRIS47.1%
Distress Probability MLnan%

2. Market Context & Competitive Position

196
NY Hospitals
-17.5%
State Median Margin
33
Comparable Hospitals

NY has 196 Medicare-certified hospitals with a median operating margin of -17.5%. The target's margin of -100.0% places it below the state median. Among 33 size-comparable peers (16-66 beds), the median margin is -15.3%. The target's below-peer margin suggests operational improvement opportunity.

3. RCM Performance Analysis — Comparable Hospitals

Comps selected by bed count (16-66), prioritizing same-state peers. 33 hospitals in the comp set.

HospitalStateBedsRevenueMargin
UNITY SPECIALITY HOSPITAL (Target)NY33$4.5M-100.0%
GLEN COVE HOSPITALNY54$176.5M-24.6%
CORNING HOSPITALNY65$169.3M5.0%
CLAXTON HEPBURN MEDICAL CENTERNY38$106.9M-16.0%
NATHAN LITTAUER HOSPITAL & NURNY57$104.5M-21.6%
TERENCE CARDINAL COOKE HEALTH NY56$99.3M-10.7%
ST ANTHONYS COMMUNITY HOSPITALNY60$87.9M18.0%
CHENANGO MEMORIAL HOSPITALNY58$80.0M-6.2%
ALICE HYDE MEDICAL CENTERNY40$79.7M-29.4%

4. Predicted Improvement Opportunities

Improvement targets set at P75 of comparable peers with 60% gap closure assumption. Coefficients calibrated to published research bands. Total EBITDA uplift: $341K (764bps margin improvement).

LeverCurrentTargetEBITDA ImpactMarginRamp
Denial Rate Reduction12.0%6.5%$94K+211bp12mo
Net Collection Rate93.5%97.0%$94K+210bp18mo
Cost to Collect4.5%2.5%$89K+200bp12mo
A/R Days Reduction5200.0%3800.0%$54K+122bp9mo
Clean Claim Rate88.0%96.0%$10K+22bp6mo

5. EBITDA Bridge

Denial Rate Reduction
$94K
Net Collection Rate
$94K
Cost to Collect
$89K
A/R Days Reduction
$54K
Clean Claim Rate
$10K
Total EBITDA Uplift$341K
Current EBITDA$-7.3M
+ RCM Uplift+$341K
Pro Forma EBITDA$-6.9M
Current Margin-100.0%
Pro Forma Margin-154.9%
WC Released (1x)$171K

6. Returns Analysis — Scenario Matrix

5-year hold, 5.5x leverage, 3% organic growth, 10%/yr debt paydown. Base case uses 100% of predicted RCM uplift. Bull case: 130% uplift at lower entry. Bear case: 50% uplift at higher entry.

ScenarioEntryExitEquity InEquity OutMOICIRR
Base Case10.0x10.0x$-11.2M$-44.4M0.00x-100.0%
Base (11x exit)10.0x11.0x$-11.2M$-52.5M0.00x-100.0%
Bull Case9.0x11.0x$-10.0M$-55.0M0.00x-100.0%
Bull (12x exit)9.0x12.0x$-10.0M$-63.0M0.00x-100.0%
Bear Case11.0x10.0x$-12.3M$-42.5M0.00x-100.0%
Bear (11x exit)11.0x11.0x$-12.3M$-50.8M0.00x-100.0%

7. Key Risks & Mitigants

SeverityRisk FactorMitigant
HighNegative operating marginRCM uplift bridge shows clear path to profitability; working capital release provides near-term cash cushion

8. Data Sources & Methodology Appendix

Data Sources

  • CMS HCRIS Cost Reports (Medicare-certified hospitals)
  • CMS Medicare Utilization (DRG-level volumes)
  • CMS Chronic Conditions (county-level disease prevalence)
  • HCRIS multi-year trend data (financial time series)

Comparable Selection

  • 33 hospitals with 16-66 beds
  • Same-state prioritization (n=34)
  • Comp margins: P25=-25.1% / P50=-15.3% / P75=-7.5%

Bridge Methodology

  • Targets: P75 of comparable peers (60% gap closure)
  • Denial: avoidable share = 35% of delta × NPR
  • AR: bad debt coefficient = $0.65 per day per $1K NPR
  • NCR: 60% coefficient on collection rate improvement
  • CDI: 0.75% of Medicare revenue per 0.01 CMI point

Returns Assumptions

  • Leverage: 5.5x entry (84.6% debt / 15.4% equity)
  • Organic growth: 3% annual EBITDA growth
  • Debt paydown: 10% of principal per year
  • Hold period: 5 years

Generated by SeekingChartis on April 26, 2026. All predictions use public data only. Confidence intervals calibrated via split conformal prediction (90% coverage target). This memo is for informational purposes and does not constitute investment advice.